1
|
Miki Y, Swensen J, Shattuck-Eidens D, et
al: A strong candidate for the breast and ovarian cancer
susceptibility gene BRCA1. Science. 266:66–71. 1994. View Article : Google Scholar : PubMed/NCBI
|
2
|
Wooster R, Bignell G, Lancaster J, et al:
Identification of the breast cancer susceptibility gene BRCA2.
Nature. 378:789–792. 1995. View
Article : Google Scholar : PubMed/NCBI
|
3
|
Antoniou A, Pharoah PDP, Narod S, et al:
Average risks of breast and ovarian cancer associated with BRCA1 or
BRCA2 mutations detected in case series unselected for family
history: a combined analysis of 22 studies. Am J Hum Genet.
72:1117–1130. 2003. View
Article : Google Scholar
|
4
|
BIC. http://research.nhgri.nih.gov/bic.
|
5
|
Santarosa M, Viel A and Boiocchi M: Splice
variant lacking the transactivation domain of the BRCA2 gene and
mutations in the splice acceptor site of intron. Genes Chromosomes
Cancer. 26:381–382. 1999. View Article : Google Scholar : PubMed/NCBI
|
6
|
Futreal PA, Liu Q, Shattuck-Eidens D, et
al: BRCA1 mutations in primary breast and ovarían
carcinomas. Science. 266:120–122. 1994. View Article : Google Scholar
|
7
|
Arena JF, Smith S, Plewinska M, et al:
BRCA1 mutations in African American women (abstract). Am J
Hum Genet. (Suppl)59:A341996.
|
8
|
Stoppa-Lyonnet D, Laurent-Puig P, Essioux
L, et al: BRCA1 sequence variations in 160 individuals referred to
a breast/ovarian family cancer clinic. Institut Curie Breast Cancer
Group. Am J Hum Genet. 60:1021–1030. 1997.
|
9
|
Gao Q, Neuhausen S, Cummings S, et al:
Recurrent germ-line BRCA1 mutations in extended African American
families with early-onset breast cancer. Am J Hum Genet.
60:1233–1236. 1997.PubMed/NCBI
|
10
|
Newman B, Mu H, Butler LM, et al:
Frequency of breast cancer attributable to BRCA1 in a
population-based series of American women. JAMA. 279:915–921. 1998.
View Article : Google Scholar : PubMed/NCBI
|
11
|
Panguluri RCK, Brody LC, Modali R, et al:
BRCA1 mutations in African Americans. Hum Genet. 105:28–31.
1999. View Article : Google Scholar
|
12
|
Dangel J, Wagner-Costalas J, Bove B, et
al: Novel germline BRCA1 mutation (155del4) in an African American
with early-onset breast cancer. Hum Mutat. 14:5451999. View Article : Google Scholar : PubMed/NCBI
|
13
|
Mefford HC, Baumbach L, Panguluri RC, et
al: Evidence for a BRCA1 founder mutation in families of
West African ancestry. Am J Hum Genet. 65:575–578. 1999.
|
14
|
Gao Q, Adebamowo CA, Fackenthal J, et al:
Protein truncating BRCA1 and BRCA2 mutations in African women with
pre-menopausal breast cancer. Hum Genet. 107:192–194. 2000.
View Article : Google Scholar : PubMed/NCBI
|
15
|
Gao Q, Tomlinson G, Das S, et al:
Prevalence of BRCA1 and BRCA2 mutations among clinic-based African
American families with breast cancer. Hum Genet. 107:186–191. 2000.
View Article : Google Scholar : PubMed/NCBI
|
16
|
Shen D, Wu Y, Subbarao M, Bhat H, Chillar
R and Vadgama JV: Mutation analysis of BRCA1 gene in
African-American patients with breast cancer. J Natl Med Assoc.
92:29–35. 2000.PubMed/NCBI
|
17
|
Nanda R, Schumm LP, Cummings S, et al:
Genetic testing in an ethnically diverse cohort of high-risk women:
a comparative analysis of BRCA1 and BRCA2 mutations in American
families of European and African ancestry. JAMA. 294:1925–1933.
2005. View Article : Google Scholar
|
18
|
Haffty DH, Choi S, Goyal A, et al: Breast
cancer in young women (YBC): prevalence of BRCA1/2 mutations and
risk of secondary malignancies across diverse racial groups. Ann
Oncol. 20:1653–1659. 2009. View Article : Google Scholar : PubMed/NCBI
|
19
|
Neuhausen SL, Godwin AK, Gershoni-Baruch
R, et al: Haplotype and phenotype analysis of nine recurrent BRCA2
mutations in 111 families: results of an international study. Am J
Hum Genet. 62:1381–1388. 1998. View
Article : Google Scholar : PubMed/NCBI
|
20
|
El-Tamer MB and Wait RB: Age at
presentation of African-American and Caucasian breast cancer
patients. J Am Coll Surg. 188:237–240. 1999. View Article : Google Scholar : PubMed/NCBI
|
21
|
Jemal A, Siegel R, Ward E, et al: Cancer
statistics. CA Cancer J Clin. 56:106–130. 2006.
|
22
|
International Agency for Research on
Cancer. GLOBOCAN. 2002, http://www-dep.iarc.fr/.
|
23
|
MacMahon B: Epidemiology and the causes of
breast cancer. Int J Cancer. 118:2373–2378. 2006. View Article : Google Scholar : PubMed/NCBI
|
24
|
Adebamowo CA and Adekunle OO:
Case-controlled study of the epidemiological risk factors for
breast cancer in Nigeria. Br J Surg. 86:665–668. 1999. View Article : Google Scholar : PubMed/NCBI
|
25
|
Eley JW, Hill HA, Chen VW, et al: Racial
differences in survival from breast cancer: results of the National
Cancer Institute Black/White Cancer Survival Study. JAMA.
272:947–954. 1994. View Article : Google Scholar
|
26
|
John EM, Miron A, Gong G, et al:
Prevalence of pathogenic BRCA1 mutation carriers in 5 US
racial/ethnic groups. JAMA. 298:2869–2876. 2007. View Article : Google Scholar : PubMed/NCBI
|
27
|
Carey LA, Perou CM, Livasy CA, et al:
Race, breast cancer subtypes, and survival in the Carolina Breast
Cancer Study. JAMA. 295:2492–2502. 2006. View Article : Google Scholar : PubMed/NCBI
|
28
|
Kurian AW, Gong GD, John EM, et al:
Performance of prediction models for BRCA mutation carriage in
three racial/ethnic groups: findings from the Northern California
Breast Cancer Family Registry. Cancer Epidemiol Biomarkers Prev.
18:1084–1091. 2009. View Article : Google Scholar
|